16
Participants
Start Date
April 30, 2013
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
PF-06305591
150 mg PF 06305591 will be administered to subjects as a 100 mL extemporaneous prepared oral solution once.
Capsaicin challenge
110 mg capsaicin cream (Axsain®) will be applied topically at each visit.
Placebo
Placebo will be administered to subjects as a 100 mL extemporaneous prepared oral solution once.
Capsaicin challenge
110 mg capsaicin cream (Axsain®) will be applied topically at each visit.
Pfizer Investigational Site, Brussels
Lead Sponsor
Pfizer
INDUSTRY